The Rise of Personalized Supplement Formulations — And Why They're Harder to Test Than You'd Think

Somewhere around 2022, direct-to-consumer supplement brands realized that “personalized” wasn’t just a marketing angle — it was a business model. Companies like Baze, Persona, and Care/of built subscription empires around the idea that your daily pack should reflect your bloodwork, your age, and your actual diet gaps, not just what happens to move well on Amazon. By 2025, the global personalized nutrition market had crossed an estimated $15 billion in annual value, and analysts tracking the segment project a compound annual growth rate above 9% through the end of the decade.

What doesn’t get talked about enough is the testing problem bundled with that personalization promise.

”One Product” Is No Longer One SKU

Traditional supplement testing assumes a relatively stable product catalog. You’ve got 12 SKUs, each with defined specifications, established analytical methods, and a stability profile you’ve verified over 24 months. Testing at 1% of batches under 21 CFR Part 111 is manageable. Your COA template covers it.

Personalized supplements break that model entirely. When a brand offers 40+ nutrient variables and assembles custom daily packs algorithmically, a single fulfillment center might be shipping hundreds of unique formulation combinations on any given day. Each of those combinations is, technically, its own product under FDA’s regulatory framework — with its own identity, purity, and potency specifications that need to be defined and verified before it ships.

We’ve seen brands come to us after scaling to several thousand orders per month only to realize that their product catalog had quietly expanded to 600+ unique SKU combinations. They were testing exactly zero of them appropriately. Not because they were being reckless — they genuinely hadn’t mapped their manufacturing model against the cGMP requirements that govern it.

What FDA’s cGMPs Actually Require for Custom Formulations

21 CFR Part 111 doesn’t carve out exceptions for “personalized” products. The requirement to establish component specifications, test incoming raw materials for identity, and verify finished product potency applies to every dietary supplement — regardless of whether it was formulated by an algorithm or a nutritionist.

Under 21 CFR §111.70, manufacturers must establish specifications for each component used in a supplement. For a brand assembling custom packs from bulk ingredients, that means every vitamin, mineral, botanical, and excipient in the system needs an approved specification on file. Under §111.75, identity testing must be conducted on 100% of incoming ingredient lots — not a sample. Every lot.

The 1% finished product testing minimum under §111.75(c) is a floor, not a ceiling. For custom formulations with highly variable nutrient combinations, relying on the bare minimum is a compliance posture that doesn’t hold up well under an FDA inspection. And FDA has been increasingly active in this space. Between 2022 and 2024, dietary supplement manufacturers received more than 60 warning letters citing cGMP violations, with identity testing failures consistently appearing among the top cited issues. That trend hasn’t reversed.

One thing worth knowing about the “personalized” framing specifically: FDA doesn’t recognize the term as a regulatory category. From the agency’s perspective, your 400-unique-formula fulfillment operation is a dietary supplement manufacturer, full stop. The flexibility you offer consumers creates obligations on your quality system that a traditional single-formula manufacturer simply doesn’t face at the same scale.

The Analytical Challenges That Make Complex Matrices Harder to Test

Here’s where it gets technically interesting. Multi-ingredient matrices — and personalized packs are almost exclusively multi-ingredient — create interference problems that single-ingredient formulas don’t generate.

Take vitamin D potency testing by HPLC (USP <2751>). In a standalone vitamin D softgel, the matrix is relatively clean and the method performs reliably. Drop that same active into a formula that also contains fat-soluble antioxidants like vitamin E or CoQ10, and your extraction and separation steps need to account for co-eluting compounds. The method still works, but it needs to be validated specifically in your matrix — not just in a clean reference standard on a method development day.

This is why method validation per USP <1225> matters more, not less, as formulation complexity increases. We routinely receive samples for potency testing where the submitting brand hasn’t flagged significant co-formulants. When results don’t match expectations, the culprit is often a method that wasn’t matched to the actual sample type. That’s a fixable problem — but it costs time and reruns.

Botanical identity testing adds another layer of complexity. USP <2021> (Microscopic Identification of Plant Material) and <2022> (High-Performance Thin-Layer Chromatography for Identification of Botanical Material) are robust, well-validated methods. But they’re method-specific to each botanical. A personalized daily pack containing five botanical ingredients means five separate identity methods — each with its own reference standards, reagents, and analyst time. Multiplied across hundreds of unique formulation combinations, identity testing costs escalate quickly for brands that didn’t model this into their unit economics.

Stability is the third challenge most brands underestimate. ICH Q1A(R2) — technically written for pharmaceutical products but widely referenced in supplement stability planning — recommends accelerated stability testing at 40°C/75% RH for 6 months as a proxy for shelf life. Running stability studies on a 12-SKU catalog is routine. For a brand with 300 active formulation variants, a rigorous stability program becomes a significant line item in the quality budget, and it needs to be planned from the start rather than bolted on after launch.

When “Batch” Doesn’t Mean What It Used To

Under the traditional batch testing model, a batch is a discrete production run of a single formula. The unit of sampling is clear. Custom supplement fulfillment doesn’t always work that way.

Some brands produce weekly masterblend lots of each individual ingredient and combine them at the point of pack assembly. Others pre-fill blister packs of individual nutrients and assemble those into custom daily pouches at the fulfillment stage. The definition of “batch” — and therefore the unit of testing and the manufacturing record — isn’t always obvious.

This matters because 21 CFR §111.3 defines a batch as a specific quantity of a dietary supplement that is uniform, that is intended to meet specifications, and that is produced during a specified time period according to a single manufacturing record. For custom assembled packs, manufacturers need to think deliberately about how they define batch records — because that definition determines their testing obligations and shapes what an FDA investigator will scrutinize during an inspection.

Working with an ISO 17025 accredited laboratory that understands this landscape is genuinely useful here. A lab that only knows how to receive samples and run methods won’t help you think through sampling strategy. One with experience in supplement cGMP compliance will flag these structural issues before they become findings.

What to Actually Look for in a Testing Partner

If you’re building or scaling a personalized supplement brand, here’s what I’d prioritize when evaluating a testing laboratory:

Method flexibility over a fixed menu. Some labs operate off a standardized test menu optimized for common single-ingredient supplements. For complex multi-ingredient matrices, you need a lab that can validate methods in your specific product type — not just apply a standard procedure and hope the matrix doesn’t interfere.

ISO 17025 accreditation with dietary supplement scope. ISO 17025 accreditation means the lab’s methods have been independently assessed against an international standard for technical competence. In the US, A2LA (American Association for Laboratory Accreditation) and Perry Johnson Laboratory Accreditation are the primary accreditation bodies. Scope matters: a lab accredited for environmental water testing isn’t the same as one accredited for nutritional analysis and microbiological testing of dietary supplements.

Fluency in 21 CFR Part 111. If the lab team can’t speak clearly about cGMP requirements, finished product specification design, and what documentation FDA expects in a manufacturing record, they can’t help you stay compliant. They can only return results.

Turnaround and location. For California-based brands, proximity to an accredited lab shortens every test cycle by the two or three days of transit you’d add shipping samples across the country. When you’re iterating on formulations or responding to a customer complaint, that time matters.

The personalized supplement category is growing faster than the quality infrastructure surrounding it. The brands that build compliant, thoughtfully designed testing programs now — rather than retrofitting compliance after an Amazon suspension or an FDA inspection — will be the ones still operating at scale five years from now. The testing complexity is real, but it’s manageable when it’s planned for from the start.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• Understanding FDA Audit Readiness for Supplement Manufacturers — Aurora TIC covers the regulatory consulting side: what FDA investigators look for and how to prepare before they show up.
• Ingredient Identity Testing and Supplier Qualification for Raw Materials — Ayah Labs specializes in raw material verification and COA review for supplement ingredient sourcing.
• Canadian NHP Testing and Health Canada Compliance for Supplement Brands — Androxa handles the Canadian regulatory pathway if your personalized supplement brand is eyeing the NHP market.